Clinical Study
Clinical and Optical Coherence Tomography Angiographic Features in Patients with Postcataract Stenotrophomonas maltophilia Endophthalmitis
Table 2
Management of patients with postcataract S. maltophilia endophthalmitis.
| Cases | Specimen | Organism identified | Treatment | Complication | Systemic (IV) | Topical | Surgical |
| 1 | Vitreous aspirate | Stenotrophomonas maltophilia | Ceftazidime Vancomycin | Pred q2h Lev q2h | PPV + IOLR + SO + IOAB | IOP elevation |
| 2 | Vitreous aspirate | Stenotrophomonas maltophilia | Levofloxacin Gentamicin | Pred q2h Lev q2h Cipr q2h | PPV + IOLR + SO + IOAB | No |
| 3 | Vitreous aspirate | Stenotrophomonas maltophilia | Tobramycin Gentamicin | Pred q2h Lev q2h Gent qid | PPV + IOLR + SO + IOAB | IOP elevation |
| 4 | AC aspirate | Stenotrophomonas maltophilia | Tobramycin Gentamicin | Pred q2h Lev q2h | PPV + IOAB; PPV + IOLR + SO + IOAB | No |
|
|
AC, anterior chamber; Pred, prednisolone acetate; Lev, levofloxacin; Cipr, ciprofloxacin; Gent, gentamicin; Tobra, tobramycin; PPV, pars plana vitrectomy; IOLR, intraocular lens removal; SO, silicone oil; IOAB, intraocular antibiotics; IOP, intraocular pressure.
|